Lykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

SAN JOSE, Calif., June 4, 2024 /PRNewswire/ — Lykos Therapeutics (“Lykos”), a company dedicated to transforming mental healthcare, announced the outcome of the U.S. Food and Drug Administration’s (“FDA”) Psychopharmacologic Drugs Advisory Committee (“PDAC”), which discussed the Company’s…